6505--Dutasteride Capsules
Closed Pre-Solicitation Posted
Not the latest version. See the latest solicitation from .
- Solicitation number
- 36E79726R0029
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The VA National Acquisition Center intends to issue RFP 36E79726R0029 for an unrestricted procurement of Dutasteride Capsules (0.5mg), with formal solicitation release on or about June 22, 2026, and a response deadline of July 7, 2026, at 2:30 PM Central Time. One contract will be awarded for a one-year base period plus four pre-priced one-year option periods. This is an unrestricted procurement with no set-aside.
The contract will serve the Department of Veterans Affairs (including Consolidated Mail Order Pharmacies and State Veterans Homes), Department of Defense (including Tricare Mail Order Pharmacies), Bureau of Prisons, Indian Health Service, and Federal Health Care Center through the VA's and DoD's Pharmaceutical Prime Vendor Programs. Annual requirements total 3,912 bottles of 30-count capsules and 25,502 bottles of 90-count capsules. Distribution occurs nationwide through the respective agencies' pharmaceutical networks.
Offerors must supply the product under their own unique NDC number and exact proprietary name appearing on the label. Packaging must include a safety cap (outer deshellable and/or convertible to non-safety cap), a 120cc minimum volume bottle with cylindrical body and minimum 5.75-inch circumference, and labels sized 5.25 inches by 2 inches with 0.5-inch additional space for barcode and expiration/lot number visibility. VA labels must adhere securely atop the contractor's label; contractors shall not affix labels over existing labels. The successful offeror's label with its unique NDC shall be the only label visible on the product. Solicitation will be issued electronically in commercial item format via SAM.gov with no paper copies available.
Contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov or 708-786-5247 for inquiries. Contracting office: Chicago, Illinois 60141.
Notice text
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0029 for an unrestricted procurement for Dutasteride Capsules, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD) (inclusive of Tricare Mail Order Pharmacies (TMOPs)), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).
VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs.
Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere on top of the successful offeror/contractor s label. All unit of use packaging identified in the Schedule of Supplies, (Line items 1 and 2, 30 and 90 count bottles) shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number.
Solicitation # 36E79726R0029 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about June 22, 2026, with a tentative closing date of July 7, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Richard Mahario. Questions can be e-mailed to Richard.Mahario@va.gov.
The estimated annual requirements are as follows:
REQUIREMENT DESCRIPTION
ITEM
DESCRIPTION
PACKAGE SIZE (Tablets per Bottle)
TOTAL ESTIMATED ANNUAL USAGE (Bottles)
1
Dutasteride 0.5MG Capsules
30
3,912
2
Dutasteride 0.5MG Capsules
90
25,502
Files
| File | Type | Posted |
|---|---|---|
| 36E79726R0029_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Dutasteride Capsules | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity